Latigo Biotherapeutics annual revenue
2024
2025
Latigo Biotherapeutics Revenue Growth & History (LTGO)
Latigo Biotherapeutics reported $4,000 in revenue for fiscal 2025, a decrease of 99.80% from the previous fiscal year.
View full Latigo Biotherapeutics company overviewLatigo Biotherapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4,000 | −$2.0M | −99.80% |
| 2024 | 2024-12-31 | $2.0M | — | — |
Latigo Biotherapeutics quarterly revenue
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
Latigo Biotherapeutics revenue growth trends
Latigo Biotherapeutics's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Latigo Biotherapeutics source filings ↗